+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
3SBio Inc - logo

3sbio is a biotechnology company that creates biopharmaceutical products. The company was incorporated in 2006, and is headquartered in Shenyang, China. It is a subsidiary of Decade Sunshine Limited. Their products include TPIAO, a recombinant human thrombopoietin for thrombocytopenia; and EPIAO, an injectable recombinant human erythropoietin for anemia associated with chronic kidney disease (CKD) and chemotherapy, as well as to reduce allogeneic blood transfusion in surgery patients. 3sbio sell their products to a range of countries including: Brazil, Colombia, Costa Rica ,Dominican Republic, Egypt, El Salvador, Guatemala, Laos, Mongolia, Myanmar, Pakistan, Paraguay, Philippines, Sri Lanka, Thailand and Trinidad and Tobago.

From
Regenerative Medicine Collaboration and Licensing Deals 2019-2024 - Product Thumbnail Image

Regenerative Medicine Collaboration and Licensing Deals 2019-2024

  • Report
  • November 2024
  • 700 Pages
  • Global
From
From
Erythropoietin Stimulating Agents Market 2024-2028 - Product Thumbnail Image

Erythropoietin Stimulating Agents Market 2024-2028

  • Report
  • October 2024
  • 137 Pages
  • Global
From
From
From
Erythropoietin (EPO) Market Report 2025 - Product Thumbnail Image

Erythropoietin (EPO) Market Report 2025

  • Report
  • April 2025
  • 175 Pages
  • Global
From
From
Regenerative Medicine for Cartilage Market Report 2025 - Product Thumbnail Image

Regenerative Medicine for Cartilage Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Biologics Market Report 2025 - Product Thumbnail Image

Biologics Market Report 2025

  • Report
  • March 2025
  • 400 Pages
  • Global
From
From
From
From
End-Stage Renal Disease - Pipeline Insight, 2025 - Product Thumbnail Image

End-Stage Renal Disease - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Loading Indicator